Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts
Guest JD et al. Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts. J Neurosci Res 1997; 50: 888-905.
Acidic fibroblast growth factor prevents death of spinal cord motoneurons in newborn rats after nerve section
Cuevas P, Carceller F, Gimenez-Gallego G. Acidic fibroblast growth factor prevents death of spinal cord motoneurons in newborn rats after nerve section. Neurol Res 1995; 17: 396-399.
Acute transverse myelitis in the emergency department: A case report and review of the literature
Kelley CE, Mathews J, Noskin GA. Acute transverse myelitis in the emergency department: a case report and review of the literature. J Emerg Med 1991; 9: 417-420.
Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production
Albrecht PJ et al. Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production. Neurobiol Dis 2003; 13: 89-101.
Delivery of neurotrophic factors to the central nervous system: Pharmacokinetic considerations
Thorne RG, Frey II WH. Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet 2001; 40: 907-946.
Neuroanatomical substrates of functional recovery after experimental spinal cord injury: Implications of basic science research for human spinal cord injury
Basso DM. Neuroanatomical substrates of functional recovery after experimental spinal cord injury: implications of basic science research for human spinal cord injury. Phys Ther 2000; 80: 808-817.
Pharmacokinetic study of recombinant human acidic fibroblast growth factor in rabbits by skin external use
Li XK et al. Pharmacokinetic study of recombinant human acidic fibroblast growth factor in rabbits by skin external use. Yao Hsueh Hsueh Pao - Acta Pharmaceutica Sinica 2002; 37: 424-427.
Delivery of neurotrophic factors to the central nervous system: Pharmacokinetic considerations
Thorne RG, Frey II WH. Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet 2001; 40: 907-946.